Gilead Sciences | 66.7000 / -2.14% |
Date/Time | 01/26 / 22:00 |
Chg. / Chg.(%) | -1.4600 / -2.14% |
Bid | 65.5300 / 200 |
Ask | 65.7300 / 100 |
Open | 67.7200 |
Previous Close | 68.1600 |
High | 68.3800 |
Low | 66.5600 |
Volume [USD] | 384,756,821.3493 |
Volume [Units] | 7,125,214 |
Price fixings | 28682 |
ISIN | US3755581036 |
Security | GILD |
Exchange | NASDAQ |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
IEX | 66.81 | ![]() |
13,103 |
TradeGate | 55.000 | ![]() |
12,057 |
Xetra | 54.27 | ![]() |
7,515 |
Frankfurt | 54.6400 | ![]() |
1,491 |
München | 54.45 | ![]() |
758 |
Stuttgart | 54.230 | ![]() |
691 |
gettex | 54.360 | ![]() |
665 |
Borsa Italia.. | 54.15 | ![]() |
623 |
Vienna Globa.. | 54.20 | ![]() |
615 |
Düsseldorf | 54.20 | ![]() |
200 |
Hamburg | 54.20 | ![]() |
115 |
Hannover | 54.60 | ![]() |
100 |
Berlin | 54.58 | ![]() |
0 |
Lang & Schwa.. | 54.110 | ![]() |
|
NASDAQ | 66.7000 | ![]() |
7,125,214 |
Cboe US | 66.69 | 561,682 | |
London Inter.. | 67.69 | 6,663 | |
Mexico | 1,333.00 | ![]() |
146 |
Borsa Italia.. | 54.71 | ![]() |
20 |
News
- NICE recommends Jyseleca® ▼(filgotinib) on NHS in landmark decision for rheumatoid arthritis
01/21/2021 / 08:08 - GlobeNewswire - Jounce Therapeutics Announces Initiation of Phase 1 INNATE Study of JTX-8064 (LILRB2/ILT4 Inhibitor) Monotherapy and PD-1 Inhibitor Combination Therapy in Patients with Advanced Solid Tumors
01/13/2021 / 14:00 - GlobeNewswire - Gilead holds 25.54% of Galapagos shares
01/11/2021 / 22:01 - GlobeNewswire - Remdesivir could work against new COVID strains - Gilead
01/11/2021 / 15:21 - TeleTrader - Intercept Appoints Jared M. Freedberg as General Counsel and Secretary
01/11/2021 / 14:00 - GlobeNewswire